Preferential Cleavage of the Coronavirus Defective Viral Genome by Cellular Endoribonuclease with Characteristics of RNase L

Overview

Journal Virol J

Publisher Biomed Central

Specialty Microbiology

Date 2024 Nov 2

PMID 39487538

Authors

Ching-Hung Lin

Hsuan-Yung Lin

Chun-Chun Yang

Hsuan-Wei Hsu

Feng-Cheng Hsieh

Cheng-Yao Yang

Hung-Yi Wu

Affiliations

Soon will be listed here.

Abstract

In testing whether coronavirus defective viral genome 12.7 (DVG12.7) with transcription regulating sequence (TRS) can synthesize subgenomic mRNA (sgmRNA) in coronavirus-infected cells, it was unexpectedly found by Northern blot assay that not only sgmRNA (designated sgmDVG 12.7) but also an RNA fragment with a size less than sgmDVG 12.7 was identified. A subsequent study demonstrated that the identified RNA fragment (designated clvDVG) was a cleaved RNA product originating from DVG12.7, and the cleaved sites were located in the loop region of stem‒loop structure and after UU and UA dinucleotides. clvDVG was also identified in mock-infected HRT-18 cells transfected with DVG12.7 transcript, indicating that cellular endoribonuclease is responsible for the cleavage. In addition, the sequence and structure surrounding the cleavage sites can affect the cleavage efficiency of DVG12.7. The cleavage features are therefore consistent with the general criteria for RNA cleavage by cellular RNase L. Furthermore, both the cleavage of rRNA and the synthesis of clvDVG were also identified in A549 cells. Because (i) the cleavage sites occurred predominantly after single-stranded UA and UU dinucleotides, (ii) the sequence and structure surrounding the cleavage sites affected the cleavage efficiency, (iii) the cleavage of rRNA is an index of the activation of RNase L, and (iv) the cleavage of both rRNA and DVG12.7 was identified in A549 cells, the results together indicated that the preferential cleavage of DVG12.7 is correlated with cellular endoribonuclease with the characteristics of RNase L and such cleavage features have not been previously characterized in coronaviruses.

References

Wu H, Ozdarendeli A, Brian D . Bovine coronavirus 5'-proximal genomic acceptor hotspot for discontinuous transcription is 65 nucleotides wide. J Virol. 2006; 80(5):2183-93. PMC: 1395388. DOI: 10.1128/JVI.80.5.2183-2193.2006. View

Ozdarendeli A, Ku S, Rochat S, Williams G, Senanayake S, Brian D . Downstream sequences influence the choice between a naturally occurring noncanonical and closely positioned upstream canonical heptameric fusion motif during bovine coronavirus subgenomic mRNA synthesis. J Virol. 2001; 75(16):7362-74. PMC: 114971. DOI: 10.1128/JVI.75.16.7362-7374.2001. View

Birdwell L, Zalinger Z, Li Y, Wright P, Elliott R, Rose K . Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon. J Virol. 2016; 90(6):3160-72. PMC: 4810646. DOI: 10.1128/JVI.03036-15. View

Vkovski P, Kratzel A, Steiner S, Stalder H, Thiel V . Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2020; 19(3):155-170. PMC: 7592455. DOI: 10.1038/s41579-020-00468-6. View

Silverman R, Skehel J, James T, Wreschner D, Kerr I . rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells. J Virol. 1983; 46(3):1051-5. PMC: 256583. DOI: 10.1128/JVI.46.3.1051-1055.1983. View

Dong B, Silverman R . Alternative function of a protein kinase homology domain in 2', 5'-oligoadenylate dependent RNase L. Nucleic Acids Res. 1998; 27(2):439-45. PMC: 148198. DOI: 10.1093/nar/27.2.439. View

Cooper D, Banerjee S, Chakrabarti A, Garcia-Sastre A, Hesselberth J, Silverman R . RNase L targets distinct sites in influenza A virus RNAs. J Virol. 2014; 89(5):2764-76. PMC: 4325751. DOI: 10.1128/JVI.02953-14. View

Gorbalenya A, Enjuanes L, Ziebuhr J, Snijder E . Nidovirales: evolving the largest RNA virus genome. Virus Res. 2006; 117(1):17-37. PMC: 7114179. DOI: 10.1016/j.virusres.2006.01.017. View

Han J, Wroblewski G, Xu Z, Silverman R, Barton D . Sensitivity of hepatitis C virus RNA to the antiviral enzyme ribonuclease L is determined by a subset of efficient cleavage sites. J Interferon Cytokine Res. 2005; 24(11):664-76. DOI: 10.1089/jir.2004.24.664. View

10.

Paul D, Bartenschlager R . Architecture and biogenesis of plus-strand RNA virus replication factories. World J Virol. 2013; 2(2):32-48. PMC: 3785047. DOI: 10.5501/wjv.v2.i2.32. View

11.

Silverman R . Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol. 2007; 81(23):12720-9. PMC: 2169107. DOI: 10.1128/JVI.01471-07. View

12.

Dong B, Xu L, Zhou A, Hassel B, Lee X, Torrence P . Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase. J Biol Chem. 1994; 269(19):14153-8. View

13.

Zhou A, Paranjape J, Brown T, Nie H, Naik S, Dong B . Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L. EMBO J. 1997; 16(21):6355-63. PMC: 1170242. DOI: 10.1093/emboj/16.21.6355. View

14.

Bisbal C, Silverman R . Diverse functions of RNase L and implications in pathology. Biochimie. 2007; 89(6-7):789-98. PMC: 2706398. DOI: 10.1016/j.biochi.2007.02.006. View

15.

Han J, Barton D . Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA. RNA. 2002; 8(4):512-25. PMC: 1370272. DOI: 10.1017/s1355838202020617. View

16.

Washenberger C, Han J, Kechris K, Jha B, Silverman R, Barton D . Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L. Virus Res. 2007; 130(1-2):85-95. PMC: 2186174. DOI: 10.1016/j.virusres.2007.05.020. View

17.

Lin C, Chen B, Chao D, Hsieh F, Yang C, Hsu H . Unveiling the biology of defective viral genomes in vitro and in vivo: implications for gene expression and pathogenesis of coronavirus. Virol J. 2023; 20(1):225. PMC: 10559480. DOI: 10.1186/s12985-023-02189-7. View

18.

Lin C, Yang C, Wang M, Ou S, Lo C, Tsai T . Effects of Coronavirus Persistence on the Genome Structure and Subsequent Gene Expression, Pathogenicity and Adaptation Capability. Cells. 2020; 9(10). PMC: 7589090. DOI: 10.3390/cells9102322. View

19.

Stark G, Dower W, Schimke R, Brown R, Kerr I . 2-5A synthetase: assay, distribution and variation with growth or hormone status. Nature. 1979; 278(5703):471-3. DOI: 10.1038/278471a0. View

20.

Pasternak A, Spaan W, Snijder E . Nidovirus transcription: how to make sense...?. J Gen Virol. 2006; 87(Pt 6):1403-1421. DOI: 10.1099/vir.0.81611-0. View